Home » Posts tagged with » GLR2007
Gan & Lee gets FDA orphan drug status for GLR2007 in malignant glioma
Gan & Lee Pharmaceuticals has been given orphan drug designation from the US Food and Drug Administration (FDA) for GLR2007 for the treatment of malignant glioma, an aggressive primary brain tumor. According to the Chinese biopharma company, GLR2007 is an inhibitor of cyclin-dependent kinase 4/6 (CDK 4/6), which is being developed for the treatment of […]
Business News Today
- Boxlight acquires AV solutions provider Sahara Presentation System
- SSGT II acquires two self storage facilities near Tampa, Florida
- Preferred Apartment Communities to sell student housing portfolio to TREP
- Corbion, Total to build €200m PLA bioplastics plant in France
- iPipeline acquires Impact Financial Systems
- Nautilus Solar Energy acquires 17MW solar portfolio from Pine Gate Renewables
- Palladium Equity Partners acquires majority stake in Trachte USA from MPE Partners
- The Hilb Group acquires life and health agency Ganim Benefits in Connecticut
- La Brea Bakery to invest in automation processes at Van Nuys bakery
- REG begins construction on single wind turbine project in Minnesota
